Parkinson's and Alzheimer's diseases are the two most common neurodegenerative disorders, affecting millions of people worldwide. Published in the Journal of Neuroscience, new research from the ...

This review examines how GLP-1 receptor agonists may influence neurodegenerative disease biology through metabolic, ...

Northwestern University researchers have reported that levetiracetam, a long-established anti-epileptic medicine, prevented ...

A series of recent studies has pinpointed the specific molecules and biological pathways through which physical activity protects the brain from aging, disease, and toxic protein buildup. Researchers ...

A study published in Molecular Psychiatry reveals a path of cause-effect molecular events that can lead to Alzheimer's ...

Pharmaceutical residues in aquatic environments are increasingly recognized as hidden neurotoxic threats. New research reveals that chronic exposure to environmentally relevant levels of ephedrine—a ...

Researchers find that a common glaucoma drug, acetazolamide, can reverse brain changes and prevent relapse in opioid use disorder.